The Life Insurance Market
A breakthrough has been made in the development of drugs to help stave off the need to claim on sickness insurance for dementia.
Researchers at Edinburgh University have discovered a compound that can slow down the decaying of the brain cells, which could end up helping millions.
The drug, UOE1961, can block enzymes that attack hormones which cause the brain to age, according to the study published in the Journal of Neuroscience.
Dr Rick Davis of the Wellcome Trust, which supports the research, notes that "advancing this compound towards clinical trials takes us a step closer to finding a drug that could have far reaching implications as the population ages."
Those implications could involve people not claiming on the sickness insurance until much later in life.
Post your own comment